Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
1.340
-0.060 (-4.29%)
At close: Oct 10, 2025, 4:00 PM EDT
1.320
-0.020 (-1.49%)
After-hours: Oct 10, 2025, 7:48 PM EDT
Fractyl Health Stock Forecast
Stock Price Forecast
The 4 analysts that cover Fractyl Health stock have a consensus rating of "Strong Buy" and an average price target of $6.90, which forecasts a 414.93% increase in the stock price over the next year. The lowest target is $3.60 and the highest is $10.
Price Target: $6.90 (+414.93%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Fractyl Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +497.01% | Sep 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +571.64% | Sep 15, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $3.6 | Strong Buy | Initiates | $3.6 | +168.66% | Aug 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $6 | Strong Buy | Maintains | $12 → $6 | +347.76% | Aug 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $10 | Buy | Maintains | $18 → $10 | +646.27% | Feb 3, 2025 |
Financial Forecast
Revenue This Year
n/a
from 93.00K
Revenue Next Year
n/a
EPS This Year
-1.56
from -1.62
EPS Next Year
-1.21
from -1.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.37 | -1.04 | |||
| Avg | -1.56 | -1.21 | |||
| Low | -1.64 | -1.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.